title: Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?
authors.forename: Mary E
authors.initials: ME
authors.lastname: Rinella
mesh_terms: D005234:Fatty Liver / Q000401:mortality* / Q000473:pathology*; D005260:Female; D019698:Hepatitis C, Chronic / Q000401:mortality* / Q000473:pathology*; D006801:Humans; D008103:Liver Cirrhosis / Q000401:mortality* / Q000473:pathology*; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease